Online Program Home
My Program

Keyword Search

Legend:
CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Keyword Search Criteria: equivalence returned 17 record(s)
Sunday, 07/29/2018
Optimal Designs for Comparison of Response Surfaces
Mong-Na Lo Huang, National Sun Yat-Sen University; Tzu-Lung Yuan, National Sun Yat-sen University; Chi-Hsiang Chu, Kaohsiung Chang Gung Memorial Hospital
4:35 PM

Monday, 07/30/2018
Nonparametric Testing for Multiple Survival Functions with Non-Inferiority Margins
Hsin-wen Chang, Academia Sinica; Ian W. McKeague, Columbia University


Absence of Evidence Is Not Evidence of Absence: a Better Parallel Trends Test
Alyssa Bilinski, Harvard Graduate School of Arts and Sciences; Laura Hatfield, Harvard Medical School


Assessing Therapeutic Equivalence of Brand and Generic Drugs Using Observational Data
Lamar Hunt, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Daniel Scharfstein, Johns Hopkins University; Irene Murimi, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Jodi Segal, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Ravi Varadhan, Johns Hopkins University; Ramin Mojtabai, Johns Hopkins Bloomberg SPH


Absence of Evidence Is Not Evidence of Absence: a Better Parallel Trends Test
Alyssa Bilinski, Harvard Graduate School of Arts and Sciences; Laura Hatfield, Harvard Medical School
10:00 AM

Assessing Therapeutic Equivalence of Brand and Generic Drugs Using Observational Data
Lamar Hunt, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Daniel Scharfstein, Johns Hopkins University; Irene Murimi, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Jodi Segal, Johns Hopkins Bloomberg SPH & OptumLabs Visiting Fellows; Ravi Varadhan, Johns Hopkins University; Ramin Mojtabai, Johns Hopkins Bloomberg SPH
12:10 PM

Evaluation of Regional Efficacy Equivalence in Developing Biosimilars
Ryuji Uozumi, Kyoto University Graduate School of Medicine; Shinjo Yada, A2 Healthcare Corporation
3:20 PM

Tuesday, 07/31/2018
New Proposal for Equivalence Criteria in Bioequivalence Study with Binary Clinical Endpoint
Mengdie Yuan, Food and Drug Administration; Jingyu Luan, Food and Drug Administration


Agreement and Individual Bioequivalence: A New Look
Tie-Hua Ng, FDA/CBER


Comparing the Reliability of Related Populations with the Probability of Agreement
Nathaniel Stevens, University of San Francisco
8:55 AM

Optimal Regression Designs Under the Second-Order Least Squares Estimator
Julie Zhou, University of Victoria; Chi-Kuang Yeh, University of Victoria
2:05 PM

Wednesday, 08/01/2018
Sample Size Allocation in Multi-Regional Equivalence Studies
Jason Liao, Merck & Co. Inc.; Ziyi Yu, Jazz Pharmaceuticals Inc; Yulan Li, Myovant Sciences
8:50 AM

A Reflection of the Statistical Assessment for Analytical Similarity and Beyond ----Are We Addressing the Right Question?
Aili Cheng, Pfizer
9:35 AM

Bayesian Framework for Tier 1 Analytical Biosimilarity Assessment
Yanbing Zheng, AbbVie; Hesham Fahmy, AbbVie
9:50 AM

Alternative Guarantees for Non-Inferiority and Equivalence Testing with a Data-Dependent Margin
Harlan Campbell, University of British Columbia
12:05 PM

T-Optimal Design for Multivariate Polynomial Regression Using Semidefinite Programming
Yuguang Yue, The University of Texas At Austin; Weng Kee Wong, UCLA; Lieven Vandenberghe, University of California, Los Angeles
2:05 PM

Thursday, 08/02/2018
On Sample Size Requirement for Analytical Similarity Assessment
Victoria Chang, AbbVie; Yi Zhao, Statistics Collaborative; Shein-Chung Chow, Food and Drug Administration
10:50 AM